JHS Svendgaard Laboratories Limited has informed the Exchange about Investor Presentation
Renaissance Global Limited has informed the Exchange about Transcript With reference to our letter Ref. No.: RGL/S&L/2022/36 dated February 02, 2022; please find enclosed herewith the transcripts of earnings Conference call on Q3 & 9M FY 2022 results of the Company, held on February 09, 2022.
Ashoka Buildcon Limited has informed the Exchange regarding Lowest Bidder (L-1) for North Frontier Railway .
Puravankara Limited has informed the Exchange about Investor Presentation
Fortis Healthcare Limitede Company at its meeting held today i.e. February 11, 2022, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the period ended on December 31, 2021. Accordingly, please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for period ended on December 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 1200 Hours IST and concluded at 1910 Hours IST. This is for your information and records please.
Shree Renuka Sugars Limited has informed the Exchange about Loss of Share Certificates
Royal Orchid Hotels Limited has informed the Exchange about Copy of Newspaper Publication
Welspun Enterprises Limited has informed the Exchange regarding allotment of 769000 securities pursuant to ESOP/ESPS at its meeting held on February 12, 2022
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2022, titled Glenmark inks agreement with Astrazeneca to commercialize its product Pulmicort Respules in Columbia.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.